Performing Arts Fort Worth Announces Return of BNSF Popular Entertainment Series
Reposted from Bass Hall
Performing Arts Fort Worth, the non-profit owner and operator of Bass Performance Hall, announced today the 2021-2022 lineup for the BNSF Popular Entertainment Series. The lineup features several audience favorites, as well as one-of-a-kind pairings and a new touring production showcasing the impact of music on pop culture.
The 2021-2022 series kicks off with the return of BRUCE ROBISON & KELLY WILLIS’ HOLIDAY SHINDIG at McDavid Studio in December, followed by country music legends THE GATLIN BROTHERS AND CRYSTAL GAYLE appearing together for the very first time on the Bass Hall stage. Ring in the new year a little early when ROBERT EARL KEEN returns to Bass Hall. Celebrate friendship in April with DANIEL TIGER’S NEIGHBORHOOD LIVE! and get ready to travel back in time when THE BRITISH INVASION- LIVE ON STAGE sweeps through Bass Hall in May. Also featured will be the SOUNDS OF RESILIENCE live concert event, a one-night only showcase of some of Fort Worth’s highly-talented local musicians. Individual tickets to all six shows will go on sale Friday, August 13.
“We are so excited not just to return to live theater,” said Performing Arts Fort Worth President and CEO Dione Kennedy, “but to welcome back the best of live entertainment, from concerts to holiday shows to family entertainment, right here in Fort Worth.”
Tickets may be purchased online at www.basshall.com or by calling the Performing Arts Fort Worth Ticket Office at 817-212-4280. The physical box office remains closed at this time. For group sales discounts please visit www.basshall.com/groups. Additional show information is available at www.basshall.com.
“As we plan to gather again, we look forward to seeing the return of some of the holiday shows we’ve always welcomed here at the Hall, as well as some new shows for patrons of all ages,” Kennedy said. “Our top priority is providing a safe environment to enjoy live performing arts experiences together again. We will continue to follow CDC and industry health and safety guidelines as we refine our reopening plans with leaders in science, technology, and medicine.”